Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.308 EUR | -0.65% | -8.06% | -21.03% |
Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.03% | 13.74M | |
+25.55% | 48.09B | |
+46.90% | 40.62B | |
-3.12% | 40.43B | |
-6.20% | 28.36B | |
+9.59% | 24.89B | |
-19.96% | 19.01B | |
+28.83% | 12.09B | |
+0.56% | 11.88B | |
-1.56% | 11.8B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Transcript : Celyad Oncology SA, 2022 Earnings Call, Mar 24, 2023